Evidence map›Paper›PMID 41681882›Full record

ArticleCancers2026

Prostate Cancer Index Density, the Ratio of Percentage of Biopsy-Positive Cores to Prostate Volume, and Predicted Lethal Disease in the EAU Intermediate Prognostic Risk Class: Analysis and Implications in 651 Consecutive Patients Treated with Robot-Assisted Radical Prostatectomy at a Tertiary Referral Centre.

Antonio Benito Porcaro, Maria Angela Cerruto, Alberto Bianchi, Riccardo Giuseppe Bertolo, Francesco Artoni, Alberto Baielli, Andrea Franceschini, Francesca Montanaro, Sonia Costantino, Alessandro Veccia and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Antonio Benito PorcaroDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.
Maria Angela CerrutoDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.
Alberto BianchiDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.
Riccardo Giuseppe BertoloDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.ORCID 0000-0003-0260-4601
Francesco ArtoniDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.
Alberto BaielliDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.
Andrea FranceschiniDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.
Francesca MontanaroDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.
Sonia CostantinoDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.
Alessandro VecciaDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.ORCID 0000-0001-5947-3206
Riccardo RizzettoDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.
Matteo BrunelliDepartment of Pathology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.
Salvatore SiracusanoDepartment of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Alessandro AntonelliDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37129 Verona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EAU intermediate prognostic prostate cancer risk classISUP tumour grade group systemlethal prostate cancerpercentage of positive prostate biopsy coresprostate biopsiesprostate cancerprostate cancer gradeprostate volumetumour upgrading

Identifiers

PMID41681882
PMCPMC12896824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.